BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 19827270)

  • 1. Alleviating effect of active hexose correlated compound (AHCC) for anticancer drug-induced side effects in non-tumor-bearing mice.
    Shigama K; Nakaya A; Wakame K; Nishioka H; Fujii H
    J Exp Ther Oncol; 2009; 8(1):43-51. PubMed ID: 19827270
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The influence of active hexose correlated compound (AHCC) on cisplatin-evoked chemotherapeutic and side effects in tumor-bearing mice.
    Hirose A; Sato E; Fujii H; Sun B; Nishioka H; Aruoma OI
    Toxicol Appl Pharmacol; 2007 Jul; 222(2):152-8. PubMed ID: 17555784
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Low-dose supplementation with active hexose correlated compound improves the immune response to acute influenza infection in C57BL/6 mice.
    Nogusa S; Gerbino J; Ritz BW
    Nutr Res; 2009 Feb; 29(2):139-43. PubMed ID: 19285605
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluation of active hexose correlated compound hepatic metabolism and potential for drug interactions with chemotherapy agents.
    Mach CM; Fugii H; Wakame K; Smith J
    J Soc Integr Oncol; 2008; 6(3):105-9. PubMed ID: 19087767
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Licochalcone A inhibits the growth of colon carcinoma and attenuates cisplatin-induced toxicity without a loss of chemotherapeutic efficacy in mice.
    Lee CK; Son SH; Park KK; Park JH; Lim SS; Kim SH; Chung WY
    Basic Clin Pharmacol Toxicol; 2008 Jul; 103(1):48-54. PubMed ID: 18484961
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Molecular hydrogen alleviates nephrotoxicity induced by an anti-cancer drug cisplatin without compromising anti-tumor activity in mice.
    Nakashima-Kamimura N; Mori T; Ohsawa I; Asoh S; Ohta S
    Cancer Chemother Pharmacol; 2009 Sep; 64(4):753-61. PubMed ID: 19148645
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Active hexose correlated compound activates immune function to decrease bacterial load in a murine model of intramuscular infection.
    Aviles H; O'Donnell P; Orshal J; Fujii H; Sun B; Sonnenfeld G
    Am J Surg; 2008 Apr; 195(4):537-45. PubMed ID: 18304499
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Amelioration by active hexose correlated compound of endocrine disturbances induced by oxidative stress in the rat.
    Ye SF; Wakame K; Ichimura K; Matsuzaki S
    Endocr Regul; 2004 Mar; 38(1):7-13. PubMed ID: 15147233
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Suppressive effect of active hexose correlated compound (AHCC) on thymic apoptosis induced by dexamethasone in the rat.
    Burikhanov RB; Wakame K; Igarashi Y; Wang S; Matsuzaki S
    Endocr Regul; 2000 Dec; 34(4):181-8. PubMed ID: 11137978
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The use of biotinylated-EGF-modified gelatin nanoparticle carrier to enhance cisplatin accumulation in cancerous lungs via inhalation.
    Tseng CL; Su WY; Yen KC; Yang KC; Lin FH
    Biomaterials; 2009 Jul; 30(20):3476-85. PubMed ID: 19345990
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The effect of active hexose correlated compound in modulating cytosine arabinoside-induced hair loss, and 6-mercaptopurine- and methotrexate-induced liver injury in rodents.
    Sun B; Wakame K; Sato E; Nishioka H; Aruoma OI; Fujii H
    Cancer Epidemiol; 2009 Oct; 33(3-4):293-9. PubMed ID: 19699163
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antitumor effectiveness and toxicity of cisplatin-loaded long-circulating and pH-sensitive liposomes against Ehrlich ascitic tumor.
    de Carvalho Maroni L; de Oliveira Silveira AC; Leite EA; Melo MM; de Carvalho Ribeiro AF; Cassali GD; de Souza CM; Souza-Fagundes EM; Caldas IR; Araújo MS; Martins-Filho OA; de Oliveira MC; Teixeira-Carvalho A
    Exp Biol Med (Maywood); 2012 Aug; 237(8):973-84. PubMed ID: 22903135
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Active hexose-correlated compound down-regulates sex-determining region Y-box 2 of pancreatic cancer cells.
    Nawata J; Kuramitsu Y; Wang Y; Kitagawa T; Tokuda K; Baron B; Akada J; Suenaga S; Kaino S; Maehara S; Maehara Y; Sakaida I; Nakamura K
    Anticancer Res; 2014 Sep; 34(9):4807-11. PubMed ID: 25202061
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Reduction of adverse effects by a mushroom product, active hexose correlated compound (AHCC) in patients with advanced cancer during chemotherapy--the significance of the levels of HHV-6 DNA in saliva as a surrogate biomarker during chemotherapy.
    Ito T; Urushima H; Sakaue M; Yukawa S; Honda H; Hirai K; Igura T; Hayashi N; Maeda K; Kitagawa T; Kondo K
    Nutr Cancer; 2014; 66(3):377-82. PubMed ID: 24611562
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Acute toxicity of long-circulating and pH-sensitive liposomes containing cisplatin in mice after intraperitoneal administration.
    Leite EA; Giuberti Cdos S; Wainstein AJ; Wainstein AP; Coelho LG; Lana AM; Savassi-Rocha PR; De Oliveira MC
    Life Sci; 2009 May; 84(19-20):641-9. PubMed ID: 19302806
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of Active Hexose Correlated Compound (AHCC) in alcohol-induced liver enzyme elevation.
    Kim H; Kim JH; Im JA
    J Nutr Sci Vitaminol (Tokyo); 2014; 60(5):348-56. PubMed ID: 25744424
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tissue distribution evaluation of stealth pH-sensitive liposomal cisplatin versus free cisplatin in Ehrlich tumor-bearing mice.
    Júnior AD; Mota LG; Nunan EA; Wainstein AJ; Wainstein AP; Leal AS; Cardoso VN; De Oliveira MC
    Life Sci; 2007 Jan; 80(7):659-64. PubMed ID: 17141809
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Supplementation with active hexose correlated compound increases survival following infectious challenge in mice.
    Ritz BW
    Nutr Rev; 2008 Sep; 66(9):526-31. PubMed ID: 18752476
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Active hexose correlated compound potentiates the antitumor effects of low-dose 5-fluorouracil through modulation of immune function in hepatoma 22 tumor-bearing mice.
    Cao Z; Chen X; Lan L; Zhang Z; Du J; Liao L
    Nutr Res Pract; 2015 Apr; 9(2):129-36. PubMed ID: 25861418
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Amifostine increases cure rate of cisplatin on ascites hepatoma 22 via selectively protecting renal thioredoxin reductase.
    Zhang J; Wang X; Lu H
    Cancer Lett; 2008 Feb; 260(1-2):127-36. PubMed ID: 18039557
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.